Codexis (CDXS) Tops Q4 EPS by 6c

Go back to Codexis (CDXS) Tops Q4 EPS by 6c

Codexis Reports Fourth Quarter and Fiscal Year 2021 Financial Results

February 24, 2022 4:05 PM UTC

Record Annual Total Revenue of $104.8M, Representing Eighth Consecutive Year of Revenue Growth

Company Guides to 2022 Total Revenues of $152-$158M; Product Revenues of $112-$118M

REDWOOD CITY, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced financial results for the fourth quarter and fiscal year ended December 31, 2021 and provided a business update.

2021 was an exceptional year for Codexis, as we more than... More